(Q46831956)

English

Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma

scientific article published on 27 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

phase II clinical trial

0 references

8

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

author name string

Premal H Patel

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

G Varuni Kondagunta

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

Lawrence Schwartz

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

Nicole Ishill

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

Jennifer Bacik

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

John DeLuca

6

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

Paul Russo

7

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

publication date

27 December 2007

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

Investigational New Drugs

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

26

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

273-276

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

https://scigraph.springernature.com/pub.10.1007/s10637-007-9107-y

0 references

A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of thalidomide in advanced metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent clinical studies of the immunomodulatory drug (IMiD) lenalidomide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thalidomide is an inhibitor of angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal two-stage designs for phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of thalidomide in renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of thalidomide for patients with advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thalidomide and lenalidomide in the treatment of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IMiDs: a novel class of immunomodulators

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18161005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-007-9107-Y

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18161005

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46831956&oldid=2133992945"